DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations
In its application, US WorldMeds submitted data from a prospective Phase II, multicenter, open-label, single-arm study of DFMO maintenance treatment of patients who had completed multiagent and multimodality therapy
J., Dalbeth, N., Stahl, E
[43] Synthesis [edit] The synthesis of tirzepatide was first disclosed in patents filed by Eli Lilly and Company in 2016
All mechanistic discussions remain exploratory in nature and are strictly limited to non-clinical laboratory research environments